Skip to main content
Fig. 3 | BMC Nephrology

Fig. 3

From: IgG4-related membranous glomerulonephritis and generalized lymphadenopathy without pancreatitis: a case report

Fig. 3

Graphical representation of main biological parameters evolution in 2013. At the beginning of the year, patient experienced a new relapse of his IgG4-RD with impairment in renal function (increase in serum creatinine) and an increase in proteinuria. A lowering of serum complement level is noticed as well as increased IgG and IgG4 levels at that time. Induction GC therapy started in march and one notices from that moment on a diminution of IgG-IgG4 level as well as an increase of serum complement level while renal function improved (normalization of serum creatinine). Around July, one sees a new increase in IgG and IgG4 levels which is consistent with dose reduction in GC therapy. New impairment in renal function was avoided this time by increasing daily dose of GC. MP = methylprednisolone; qd = daily; qod = every other day

Back to article page